Latest News about EXEL
Recent news which mentions EXEL
5 Value Stocks That Can Make You Richer in 2022
January 20, 2022
From Motley Fool
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
From Motley Fool
From Benzinga
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
January 03, 2022
From InvestorPlace
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
2 Growth Stocks Analysts Think Can Double Within 2 Years
December 15, 2021
From Motley Fool
Got $1,000? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
December 10, 2021
From Motley Fool
The Smartest Stocks to Buy With $200 in December
December 10, 2021
From Motley Fool
The Smartest Stocks to Buy With $20 Right Now
November 12, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy in November
November 04, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
From Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
Exelixis, inc (EXEL) Q3 2021 Earnings Call Transcript
November 02, 2021
Tickers
EXEL
From Motley Fool
SAVA Stock: 8 Things to Know as Cassava Sciences Rockets Higher
November 02, 2021
From InvestorPlace
Exelixis Earnings Perspective: Return On Capital Employed
November 02, 2021
Tickers
EXEL
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
2 Growth Stocks That Could Deliver 1,000% Returns
October 31, 2021
From Motley Fool
3 Biotech Stocks That Could Make You Richer
October 30, 2021
From Motley Fool
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
4 Growth Stocks With 187% to 434% Upside, According to Wall Street
October 13, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter
September 28, 2021
From Motley Fool
Exelixis's Cabometyx Scores FDA Nod In Differentiated Thyroid Cancer; ESMO Presentation
September 20, 2021
Tickers
EXEL
From Benzinga
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 2%
September 20, 2021
From Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
From Benzinga
2 Top Biotech Stocks to Buy Right Now
September 11, 2021
From Motley Fool